The global market for Discovery & Targeted Proteomics Service was valued at US$ 2373 million in the year 2023 and is projected to reach a revised size of US$ 4826 million by 2030, growing at a CAGR of 11.6% during the forecast period.
Discovery proteomics involves unbiased, large-scale analysis of proteins in complex biological samples, while targeted proteomics focuses on known proteins or specific pathways. The two complement each other. Non-targeted proteomics provides extensive protein information and the discovery of potential biomarkers, laying the foundation for subsequent in-depth research in targeted proteomics, while targeted proteomics can verify and functionally evaluate key proteins identified in non-targeted analysis, thereby achieving a more detailed understanding of biology.
North American market for Discovery & Targeted Proteomics Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Discovery & Targeted Proteomics Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Discovery & Targeted Proteomics Service in Screening and Validation of Disease Biomarkers is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Discovery & Targeted Proteomics Service include RayBiotech, Inc., Inotiv, Sapient Bioanalytics, LLC, Biogenity, Proteome Sciences, VProteomics, Creative Proteomics, Charles River Laboratories, MtoZ Biolabs, Panome Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Discovery & Targeted Proteomics Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Discovery & Targeted Proteomics Service.
The Discovery & Targeted Proteomics Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Discovery & Targeted Proteomics Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Discovery & Targeted Proteomics Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
RayBiotech, Inc.
Inotiv
Sapient Bioanalytics, LLC
Biogenity
Proteome Sciences
VProteomics
Creative Proteomics
Charles River Laboratories
MtoZ Biolabs
Panome Bio
PolyQuant GmbH
MS Bioworks
LABTOO
BGI Genomics
Biotech Pack
APPLIED PROTEIN TECHNOLOGY
OBiO Technology ( Shanghai ) Corp.,Ltd.
Suzhou PANOMIX Biomedical Tech Co.,Ltd
Novogene
OeBiotech
ChomiX Biotech Co., Ltd
Segment by Type
Discovery Proteomics
Targeted Poteomics
Segment by Application
Screening and Validation of Disease Biomarkers
Drug Development and Precision Medicine
Protein Function and Interaction Studies
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Discovery & Targeted Proteomics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Discovery & Targeted Proteomics Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Discovery Proteomics
1.2.3 Targeted Poteomics
1.3 麻豆原创 by Application
1.3.1 Global Discovery & Targeted Proteomics Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Screening and Validation of Disease Biomarkers
1.3.3 Drug Development and Precision Medicine
1.3.4 Protein Function and Interaction Studies
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Discovery & Targeted Proteomics Service 麻豆原创 Perspective (2019-2030)
2.2 Global Discovery & Targeted Proteomics Service Growth Trends by Region
2.2.1 Global Discovery & Targeted Proteomics Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Discovery & Targeted Proteomics Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Discovery & Targeted Proteomics Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Discovery & Targeted Proteomics Service 麻豆原创 Dynamics
2.3.1 Discovery & Targeted Proteomics Service Industry Trends
2.3.2 Discovery & Targeted Proteomics Service 麻豆原创 Drivers
2.3.3 Discovery & Targeted Proteomics Service 麻豆原创 Challenges
2.3.4 Discovery & Targeted Proteomics Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Discovery & Targeted Proteomics Service Players by Revenue
3.1.1 Global Top Discovery & Targeted Proteomics Service Players by Revenue (2019-2024)
3.1.2 Global Discovery & Targeted Proteomics Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Discovery & Targeted Proteomics Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Discovery & Targeted Proteomics Service Revenue
3.4 Global Discovery & Targeted Proteomics Service 麻豆原创 Concentration Ratio
3.4.1 Global Discovery & Targeted Proteomics Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Discovery & Targeted Proteomics Service Revenue in 2023
3.5 Global Key Players of Discovery & Targeted Proteomics Service Head office and Area Served
3.6 Global Key Players of Discovery & Targeted Proteomics Service, Product and Application
3.7 Global Key Players of Discovery & Targeted Proteomics Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Discovery & Targeted Proteomics Service Breakdown Data by Type
4.1 Global Discovery & Targeted Proteomics Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Discovery & Targeted Proteomics Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Discovery & Targeted Proteomics Service Breakdown Data by Application
5.1 Global Discovery & Targeted Proteomics Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Discovery & Targeted Proteomics Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Discovery & Targeted Proteomics Service 麻豆原创 Size (2019-2030)
6.2 North America Discovery & Targeted Proteomics Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2019-2024)
6.4 North America Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Discovery & Targeted Proteomics Service 麻豆原创 Size (2019-2030)
7.2 Europe Discovery & Targeted Proteomics Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2019-2024)
7.4 Europe Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Discovery & Targeted Proteomics Service 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Discovery & Targeted Proteomics Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Discovery & Targeted Proteomics Service 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Discovery & Targeted Proteomics Service 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Discovery & Targeted Proteomics Service 麻豆原创 Size (2019-2030)
9.2 Latin America Discovery & Targeted Proteomics Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Discovery & Targeted Proteomics Service 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Discovery & Targeted Proteomics Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Discovery & Targeted Proteomics Service 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RayBiotech, Inc.
11.1.1 RayBiotech, Inc. Company Details
11.1.2 RayBiotech, Inc. Business Overview
11.1.3 RayBiotech, Inc. Discovery & Targeted Proteomics Service Introduction
11.1.4 RayBiotech, Inc. Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.1.5 RayBiotech, Inc. Recent Development
11.2 Inotiv
11.2.1 Inotiv Company Details
11.2.2 Inotiv Business Overview
11.2.3 Inotiv Discovery & Targeted Proteomics Service Introduction
11.2.4 Inotiv Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.2.5 Inotiv Recent Development
11.3 Sapient Bioanalytics, LLC
11.3.1 Sapient Bioanalytics, LLC Company Details
11.3.2 Sapient Bioanalytics, LLC Business Overview
11.3.3 Sapient Bioanalytics, LLC Discovery & Targeted Proteomics Service Introduction
11.3.4 Sapient Bioanalytics, LLC Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.3.5 Sapient Bioanalytics, LLC Recent Development
11.4 Biogenity
11.4.1 Biogenity Company Details
11.4.2 Biogenity Business Overview
11.4.3 Biogenity Discovery & Targeted Proteomics Service Introduction
11.4.4 Biogenity Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.4.5 Biogenity Recent Development
11.5 Proteome Sciences
11.5.1 Proteome Sciences Company Details
11.5.2 Proteome Sciences Business Overview
11.5.3 Proteome Sciences Discovery & Targeted Proteomics Service Introduction
11.5.4 Proteome Sciences Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.5.5 Proteome Sciences Recent Development
11.6 VProteomics
11.6.1 VProteomics Company Details
11.6.2 VProteomics Business Overview
11.6.3 VProteomics Discovery & Targeted Proteomics Service Introduction
11.6.4 VProteomics Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.6.5 VProteomics Recent Development
11.7 Creative Proteomics
11.7.1 Creative Proteomics Company Details
11.7.2 Creative Proteomics Business Overview
11.7.3 Creative Proteomics Discovery & Targeted Proteomics Service Introduction
11.7.4 Creative Proteomics Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.7.5 Creative Proteomics Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Discovery & Targeted Proteomics Service Introduction
11.8.4 Charles River Laboratories Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.8.5 Charles River Laboratories Recent Development
11.9 MtoZ Biolabs
11.9.1 MtoZ Biolabs Company Details
11.9.2 MtoZ Biolabs Business Overview
11.9.3 MtoZ Biolabs Discovery & Targeted Proteomics Service Introduction
11.9.4 MtoZ Biolabs Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.9.5 MtoZ Biolabs Recent Development
11.10 Panome Bio
11.10.1 Panome Bio Company Details
11.10.2 Panome Bio Business Overview
11.10.3 Panome Bio Discovery & Targeted Proteomics Service Introduction
11.10.4 Panome Bio Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.10.5 Panome Bio Recent Development
11.11 PolyQuant GmbH
11.11.1 PolyQuant GmbH Company Details
11.11.2 PolyQuant GmbH Business Overview
11.11.3 PolyQuant GmbH Discovery & Targeted Proteomics Service Introduction
11.11.4 PolyQuant GmbH Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.11.5 PolyQuant GmbH Recent Development
11.12 MS Bioworks
11.12.1 MS Bioworks Company Details
11.12.2 MS Bioworks Business Overview
11.12.3 MS Bioworks Discovery & Targeted Proteomics Service Introduction
11.12.4 MS Bioworks Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.12.5 MS Bioworks Recent Development
11.13 LABTOO
11.13.1 LABTOO Company Details
11.13.2 LABTOO Business Overview
11.13.3 LABTOO Discovery & Targeted Proteomics Service Introduction
11.13.4 LABTOO Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.13.5 LABTOO Recent Development
11.14 BGI Genomics
11.14.1 BGI Genomics Company Details
11.14.2 BGI Genomics Business Overview
11.14.3 BGI Genomics Discovery & Targeted Proteomics Service Introduction
11.14.4 BGI Genomics Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.14.5 BGI Genomics Recent Development
11.15 Biotech Pack
11.15.1 Biotech Pack Company Details
11.15.2 Biotech Pack Business Overview
11.15.3 Biotech Pack Discovery & Targeted Proteomics Service Introduction
11.15.4 Biotech Pack Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.15.5 Biotech Pack Recent Development
11.16 APPLIED PROTEIN TECHNOLOGY
11.16.1 APPLIED PROTEIN TECHNOLOGY Company Details
11.16.2 APPLIED PROTEIN TECHNOLOGY Business Overview
11.16.3 APPLIED PROTEIN TECHNOLOGY Discovery & Targeted Proteomics Service Introduction
11.16.4 APPLIED PROTEIN TECHNOLOGY Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.16.5 APPLIED PROTEIN TECHNOLOGY Recent Development
11.17 OBiO Technology ( Shanghai ) Corp.,Ltd.
11.17.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Company Details
11.17.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
11.17.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Discovery & Targeted Proteomics Service Introduction
11.17.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.17.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Development
11.18 Suzhou PANOMIX Biomedical Tech Co.,Ltd
11.18.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Details
11.18.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
11.18.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Discovery & Targeted Proteomics Service Introduction
11.18.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.18.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Development
11.19 Novogene
11.19.1 Novogene Company Details
11.19.2 Novogene Business Overview
11.19.3 Novogene Discovery & Targeted Proteomics Service Introduction
11.19.4 Novogene Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.19.5 Novogene Recent Development
11.20 OeBiotech
11.20.1 OeBiotech Company Details
11.20.2 OeBiotech Business Overview
11.20.3 OeBiotech Discovery & Targeted Proteomics Service Introduction
11.20.4 OeBiotech Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.20.5 OeBiotech Recent Development
11.21 ChomiX Biotech Co., Ltd
11.21.1 ChomiX Biotech Co., Ltd Company Details
11.21.2 ChomiX Biotech Co., Ltd Business Overview
11.21.3 ChomiX Biotech Co., Ltd Discovery & Targeted Proteomics Service Introduction
11.21.4 ChomiX Biotech Co., Ltd Revenue in Discovery & Targeted Proteomics Service Business (2019-2024)
11.21.5 ChomiX Biotech Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
RayBiotech, Inc.
Inotiv
Sapient Bioanalytics, LLC
Biogenity
Proteome Sciences
VProteomics
Creative Proteomics
Charles River Laboratories
MtoZ Biolabs
Panome Bio
PolyQuant GmbH
MS Bioworks
LABTOO
BGI Genomics
Biotech Pack
APPLIED PROTEIN TECHNOLOGY
OBiO Technology ( Shanghai ) Corp.,Ltd.
Suzhou PANOMIX Biomedical Tech Co.,Ltd
Novogene
OeBiotech
ChomiX Biotech Co., Ltd
听
听
*If Applicable.
